SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Sysmex Corporation SSMXY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • JP • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Sysmex Corporation (SSMXY) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $8.82. It has a SharesGrow Score of 75/100, indicating a strong investment profile with 5 out of 7 criteria passed.

Financials: revenue is $508.6B, +11.8%/yr average growth. Net income is $53.7B, growing at +6.8%/yr. Net profit margin is 10.6% (healthy). Gross margin is 53.5% (+1.1 pp trend).

Balance sheet: total debt is $64.7B against $463.8B equity (Debt-to-Equity (D/E) ratio 0.14, conservative). Current ratio is 2.97 (strong liquidity). Debt-to-assets is 9.7%. Total assets: $665.3B.

Analyst outlook: 0 / 1 analysts rate SSMXY as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 78/100 (Pass), Future 20/100 (Fail), Income 55/100 (Partial).

SSMXY SharesGrow Score Overview

75/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 73/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 78/100

Gross margin is + market cap

FUTURE 20/100

Analyst outlook — as buy

INCOME 55/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SSMXY

SSMXY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

SSMXY: +11.8%/yr revenue is, +6.8%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SSMXY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet SSMXY: Debt-to-Equity (D/E) ratio 0.14 (conservative), Current ratio is 2.97 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SSMXY: Gross margin is 53.5% (+1.1 pp trend), $5B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 78/100. ≥ 70 = Pass.

View details →

Analyst outlook: 0 / 1 analysts rate SSMXY as buy (0%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

SSMXY: Net profit margin is 10.6%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range8.15-19.65

Volume4.63K

Avg Volume (30D)265.92K

Market Cap$5.5B

Beta (1Y)0.65

Dividend Yield$0.1044

Share Statistics

EPS (TTM)86.07

Shares Outstanding$623.53M

IPO Date2011-10-17

Employees10,042

CEOHisashi Ietsugu

Financial Highlights & Ratios

Revenue (TTM)$508.64B

Gross Profit$271.98B

EBITDA$121.77B

Net Income$53.67B

Operating Income$87.58B

Total Cash$90.22B

Total Debt$64.74B

Net Debt$-24.84B

Total Assets$665.27B

Price / Earnings (P/E)0.1

Price / Sales (P/S)0.01

Analyst Forecast

Rating ConsensusHold

Analysts Covering1

Buy 0% Hold 100% Sell 0%

Company Info

CountryJP

ExchangeOther OTC

CurrencyUSD

ISINUS87184P1093

Price Chart

SSMXY

Sysmex Corporation ↗ · Other OTC

Healthcare • Medical - Instruments & Supplies

8.15 52WK RANGE 19.65

People Also View

EssilorLuxottica S.A.

EssilorLuxottica S.A.

HOYA Corporation

Straumann Holding AG

Carl Zeiss Meditec AG

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message